RxDoctor Payments Data

Medical Biochemical Genetics: industry payments

Drug and device makers reported $170,213 in payments to providers registered in this specialty across Open Payments program years 20192025.

Providers
16
Received a payment
16 (100.0%)
Total reported
$170K
Average, those paid
$10,638

The average is computed only over providers who received something, because including the 0 who received nothing would produce a number that describes neither group. Totals are dominated by a small number of large royalty and consulting arrangements; the typical payment in this specialty is far smaller than the average implies.

What Medicare pays medical biochemical genetics clinicians

Part B allowed per clinician, 2024
$3,035
Of which, services
$3,035
Clinicians billing Part B
2

Across 2 medical biochemical genetics clinicians who billed Original Medicare Part B in 2024, Medicare allowed $6,071 in total — an average of $3,035 each, of which $3,035 was for services and the rest for drugs administered in the office.

This is not a salary. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.

By state

StateProvidersTotal reportedPer provider
California2$115,135$57,567
Maryland1$24,534$24,534
South Carolina1$14,839$14,839
Arizona1$6,599$6,599
Utah1$6,169$6,169
Texas2$1,469$735
New York1$536$536
Washington2$486$243
Michigan1$179$179
Wisconsin1$82$82
Pennsylvania1$77$77
Georgia1$60$60
Massachusetts1$49$49